JM is good for RNAi, not only Alnylam. Here's a quick discussion he had last week on CNBC if it hasn't been put up already.
Interesting query on how long it (sirna therapy) lasts, and his response was they have potentially a bi-annual dosing regime for one of their therapies. Which he said would be 'revolutionary'.
Big pharma may be telling Greg West they are baulking at how to fit a permanent gt cure into their model (it's actually called pre-sale tyre kicking), but the media and RNAi leaders consider it optimal.
Go BLT!
- Forums
- ASX - By Stock
- BLT
- BLT.AX says CEO and Managing Director Dr Peter French Resigned
BLT.AX says CEO and Managing Director Dr Peter French Resigned, page-114
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online